Where does Rappaport Family Institute for Research In the Medical Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rappaport Family Institute for Research In the Medical Sciences ranks #19,068 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Rappaport Family Institute for Research In the Medical Sciences's patent grant rate increasing or decreasing?

Rappaport Family Institute for Research In the Medical Sciences's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rappaport Family Institute for Research In the Medical Sciences's patents?

Rappaport Family Institute for Research In the Medical Sciences's patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rappaport Family Institute for Research In the Medical Sciences

Q: How is the Rappaport Family Institute for Research In the Medical Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 15 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rappaport ranks #19,068 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 11 technology areas.

#19,068
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.3/100): 11.6
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19068 · Foreign Corporation #19,068 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,068/49,997
PHOTO-FINISH Radius Group
CPC-FOCUS A61K · 11 areas
INNOV-PAR 48.3/100
CLAIMS-PAR 11.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radius Group, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rappaport’s 48.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (20%) Velocity 20.0 pts (41%) Breadth 11.7 pts (24%) Claim depth 7.0 pts (14%)

Qualcomm Incorporated · highest

85
Rappaport Family… · this assignee

48
3D Lighting… · lowest

7

What this shows Rappaport's Innovation Score is 48.3/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rappaport?

Each dot is one of Rappaport’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rappaport’s own 11.6 claims/patent is at or below the 13.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rappaport vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rappaport's grants concentrate

Rappaport Family Institute for Research In the Medical Sciences is a focused PatentsView assignee: 11 CPC subclasses with 86.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2018. By volume, Rappaport sits between Rwth Aachen and Rebound Technologies, Inc..

Rappaport's three-year grant acceleration

Rappaport Family Institute for Research In the Medical Sciences shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rwth Aachen

15
Radius Group

15
Rain Neuromorphics

15
Rapala VMC Oyj

15
Rausch & Pausch

15
Rave Wireless

15
Raytheon Systems

15
Rebound

15
Rappaport Family… ◀

15

What this shows Rappaport holds 15 patents at rank #19,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rappaport

By rank, the assignees closest to #19,083 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Rappaport's primary technology class.

Rappaport's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rappaport Family Institute for Research In the Medical Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	26.7%
2016	3	20.0%
2017	4	26.7%
2018	1	6.7%
2024	3	20.0%

Which technologies does Rappaport Family Institute for Research In the Medical Sciences patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 12

C07K - Peptides 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

G06F - Electric Digital Data Processing 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rappaport Family Institute for Research In the Medical Sciences's patent record in context - here's where to go next.

Rappaport Family Institute for Research In the Medical Sciences's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 86.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #19,068 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rappaport Family Institute for Research In the Medical Sciences against Rwth Aachen, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.